COMMUNIQUÉS West-GlobeNewswire

Assure Holdings Enters into First In-Network Agreement
09/09/2019
DENVER, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, entered into an agreement with a national [...]
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation
09/09/2019
Fluidigm Launches Breakthrough RNA Sequencing Library Preparation Workflow, Delivering Substantial Cost Savings and Efficiency SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ [...]
Mateon Partners With WideTrial for Data-Generating Expanded Access Programs in Cancer
09/09/2019
AGOURA HILLS, Calif. and SAN FRANCISCO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc. (OTCQB:MATN), announced today that it has executed agreements with WideTrial Inc. for an Expanded Access program (EAP) [...]
Acasti Pharma Receives Funding from the Government of Canada to Expand Production Capacity
09/09/2019
LAVAL, Quebec, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Protech Home Medical Receives $8.6 Million
09/09/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE ‎UNITED STATES CINCINNATI, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“ Protech ” or the “ Company ”) (TSXV: ‎PTQ [...]
InspireMD Provides Business Update
09/09/2019
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, [...]
Daré Bioscience Announces Completion of its Content Validity Study to Support the Continued Clinical Development of Sildenafil Cream, 3.6%, a Potential Therapy for Female Sexual Arousal Disorder
09/09/2019
Sildenafil Cream, 3.6% has the Potential to Be the First FDA-Approved Product for FSAD SAN DIEGO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, and [...]
Intercept Appoints Lisa DeFrancesco as Vice President, Investor Relations
09/09/2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Ovid Therapeutics to Present at the H.C. Wainwright 21st Annual Global Investment Conference
09/09/2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
BIOLIFE4D Becomes First U.S. Company to Successfully Demonstrate Ability to 3D Bioprint a Mini Human Heart
09/09/2019
Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles CHICAGO, Sept. 09, 2019 [...]
Synthorx to Present at the 2019 World Congress of Inflammation
09/09/2019
First-of-its-Kind Genetic Alphabet Platform Used to Design Synthorin for Autoimmune Indications SAN DIEGO, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a clinical-stage biotechnology company [...]
SubioMed to Attend American Orthopedic Foot and Ankle Society Annual Meeting in Chicago
09/09/2019
Largest Meeting of its Kind for Foot and Ankle Orthopedics Featuring World Class Companies Including Wright Medical, Depuy, Zimmer Bionet and Stryker MINNEAPOLIS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“ [...]
TYME Presents Positive Circulating Tumor Cell Data from TYME-88-Panc Study in Patients with Advanced Pancreatic Cancer at AACR PANC 2019
09/09/2019
TYME-88-PANC Phase II study showed patients being treated with SM-88, who achieved at least an 80% reduction in circulating tumor cell burden, demonstrated a 60% decrease in risk of death SM-88 is an oral, [...]
Harvard Bioscience Announces Strategic Action Plan and Financial Targets
09/09/2019
HOLLISTON, Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announces its strategic action plan and financial targets for rest of year 2019 through 2021. Key strategic actions and [...]
ORYZON’s Iadademstat Shows Efficacy Signs in Relapsed SCLC
09/09/2019
Preliminary data from CLEPSIDRA Phase II trial presented at WCLC 2019 Case study showing a 86% tumor reduction Additional data will be presented late September at ESMO-2019 MADRID and CAMBRIDGE, Mass., Sept. 09, 2019 ( [...]
InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference
09/09/2019
TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, today [...]
Mustang Bio to Present at Scientific Conferences in September 2019
09/09/2019
NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Bhang Inc. Acquires Leading Wellness Beverage Company, Red Ace Organics
09/09/2019
--First Foray in Beverage Space Positions Bhang Firmly in Health and Wellness Market --Red Ace Products Currently Sold at More Than 1,400 Locations Including Whole Foods & Amazon --Bhang Plans to Launch Red Ace- [...]
BiomX Hosting Key Opinion Leader Symposium on Novel Phage Product for Acne Prone Skin
09/09/2019
NESS ZIONA, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- BiomX Ltd., a microbiome company developing both natural and engineered phage therapies, today announced that it will host a Key Opinion Leader (KOL) meeting on a [...]

Pages